Reunion Neuroscience Inc REUN Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$1.12 unchanged at close Aug 1
Last close · Previous close $1.12
- Market cap
- At the Aug 1 close
- P/E ratio
- PausedOn last 12 months’ EPS
See the note under the price. - Diluted EPS
- PausedLast 12 months
See the note under the price. - Dividend yield
- NoneLast 12 months
Price chart
$1.12down $0.01, 0.88%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$1.12Jul 31
- Volume0.00Aug 1 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume44.42KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Aug 1 close. Total return includes reinvested dividends.Price change only, without dividends.
| Period | REUN |
|---|---|
| Short term | |
| 1M | REUN: down 0.9% |
| 3M | REUN: up 48.4% |
| YTD | REUN: up 24.4% |
| 1Y | REUN: down 72.0% |
$10,000 invested in REUN a year ago (Aug 1, 2022) would be worth about $2,800 at the close on , with dividends reinvested.
| Period | REUN |
|---|---|
| Short term | |
| 1M | REUN: down 0.9% |
| 3M | REUN: up 48.4% |
| YTD | REUN: up 24.4% |
| 1Y | REUN: down 72.0% |
$10,000 invested in REUN a year ago (Aug 1, 2022) would be worth about $2,800 at the close on , not counting dividends.
All-time high
$32.50
Closing high on . Now 96.6% below that record.
Split-adjusted daily closes since Jul 29, 2021.
Stock splits
1
1-for-5 on . Share counts adjust after each split.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q4 FY23, the quarter ended Mar 31, 2023. “Last 12 months” means the four quarters from Apr 1, 2022 to Mar 31, 2023, and balance-sheet figures are as of Mar 31, 2023.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $0.00
- Net income
- −$36.42M
- Diluted EPS
- PausedSee the note under the price.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q1 FY22 (Jun 30, 2021) | $0.00 | −$10.11M | Paused See the note under the price. |
| Q2 FY22 (Sep 30, 2021) | $0.00 | −$10.25M | Paused See the note under the price. |
| Q3 FY22 (Dec 31, 2021) | $0.00 | −$11.70M | Paused See the note under the price. |
| Q4 FY22 (Mar 31, 2022) | $0.00 | −$11.25M | Paused See the note under the price. |
| Q1 FY23 (Jun 30, 2022) | $0.00 | −$10.43M | Paused See the note under the price. |
| Q2 FY23 (Sep 30, 2022) | $0.00 | −$12.19M | Paused See the note under the price. |
| Q3 FY23 (Dec 31, 2022) | $0.00 | −$9.09M | Paused See the note under the price. |
| Q4 FY23 (Mar 31, 2023) | $0.00 | −$4.70M | Paused See the note under the price. |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Mar 31, 2021) | $774.92K | −$18.64M | Paused See the note under the price. |
| FY22 (Mar 31, 2022) | $0.00 | −$43.41M | Paused See the note under the price. |
| FY23 (Mar 31, 2023) | $0.00 | −$35.14M | Paused See the note under the price. |
Margins
- Gross —
- Operating —
- Net —
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$21.25MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$21.07MLast 12 months
- Capital spending$176.63KLast 12 months
Shareholder returns
- $62.49KLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paidNot reportedLast 12 months
Balance sheet
- $20.08MAs of Mar 31, 2023
Cash plus short- and long-term marketable securities on the Mar 31, 2023 balance sheet.
- Total debt$0.00As of Mar 31, 2023
- Net cash$20.08MAs of Mar 31, 2023
- Book value per sharePausedAs of Mar 31, 2023
See the note under the price. - 3.52As of Mar 31, 2023
Current assets divided by current liabilities on the Mar 31, 2023 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.00As of Mar 31, 2023
Total debt divided by shareholders’ equity on the Mar 31, 2023 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- −138.4%Last 12 months
Over the last 12 months, Reunion Neuroscience lost money: its net loss was 138.4% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - −97.3%Last 12 months
Over the last 12 months, Reunion Neuroscience’s net loss was 97.3% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About Reunion Neuroscience Inc
Field Trip Health Ltd
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Ontario, Canada
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
REUN news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
REUN stock FAQ
What is REUN stock’s price today?
Reunion Neuroscience (REUN) traded at $1.12 at the close on , unchanged from the previous close of $1.12.
Does REUN pay a dividend?
Reunion Neuroscience hasn’t paid a dividend in the last twelve months.
What is REUN’s all-time high?
REUN’s highest closing price was $32.50 on , adjusted for stock splits. At $1.12 at the close on , it is 96.6% below that record.
Has REUN stock ever split?
Yes, once: 1-for-5 on .
How has REUN stock performed?
Including dividends and measured to the close on , REUN has returned +24.4% so far this year and −72.0% over the past year. Past performance doesn’t predict future returns.
What sector and industry is Reunion Neuroscience in?
Reunion Neuroscience is in the Healthcare sector and the Biotechnology industry, and is headquartered in Ontario, Canada.
What exchange does REUN trade on?
Reunion Neuroscience trades on the Nasdaq under the ticker symbol REUN. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.